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Clinical evaluation of FAPlus/FNPlus bottles compared with 
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blood culture system
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Abstract : Background : The comparison of the performance of FAPlus/FNPlus bottles and combination of SA/
SN and FA/FN bottles is not yet reported. Methods : We used human blood samples to investigate microorganism 
detection rates and the time to positivity (TTP) in a before-vs.-after study (a combination of SA/SN and FA/FN 
bottles from September 2012 to August 2013 vs. FAPlus/FNPlus bottles from September 2013 to August 2014). 
Results : The microorganism detection rate was significantly higher in the later period than in the earlier period 
(11.2% vs. 9.6%, P < 0.001), particularly for Enterococcus and Streptococcus species, nonfermentative Gram-nega-
tive bacilli, and Helicobacter cinaedi. TTP for pathogens was longer when FAPlus/FNPlus bottles were used than 
when a combination of SA/SN and FA/FN bottles was used (14.9 vs. 13.3 h, P = 0.014), particularly, in the case of 
Gram-negative bacilli including Escherichia coli. Conclusion : The microorganism detection rate was improved 
with the use of FAPlus/FNPlus bottles compared with the combination of SA/SN and FA/FN bottles ; however, 
FAPlus/FNPlus bottles seemed to be inferior to SA/SN and FA/FN bottles in terms of TTP. J. Med. Invest. 67 : 90-94, 
February, 2020
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INTRODUCTION
 
Bloodstream infections are associated with a high morbidity 
and mortality (1). Blood culture is still essential for detecting 
bloodstream infections, although direct molecular detection 
methods have been developed in recent years (2). Advancements 
in blood culture techniques occurred in the 1990s following the 
introduction of automated incubators with continuous moni-
toring and enrichment of culture media (3). The BacT/Alert 
automated blood culture system (BioMérieux Co., Ltd., Tokyo, 
Japan) is one of the main systems used worldwide for the detec-
tion of bloodstream infections (4).
BioMérieux Co., Ltd. initially introduced standard aerobic 
(SA) and standard anaerobic (SN) culture bottles, followed by 
fastidious aerobic (FA) and anaerobic antibiotic neutralization 
(FN) bottles. SA/SN bottles, which contain supplemented soy-
bean-casein digest broth medium, use 1 : 9 blood : broth dilution 
ratio. Because of this low dilution, these bottles were shown to 
have low detection rates and false-negative results in hospital-
ized patients who had received antimicrobial therapy before col-
lection of blood (5). In fact, approximately 50%-90% of inpatients 
had already received antimicrobial therapy at the time of blood 
culture (6, 7), and the presence of antibiotics in the blood might 
inhibit the growth of microorganisms, particularly in SA/SN 
bottles. Unlike SA/SN bottles, FA/FN bottles contain absorbent 
charcoal and were developed to avoid the effect of antimicrobial 
agents and other substances in the blood that could inhibit bac-
terial growth (8). However, the presence of charcoal represents a 
major limiting factor for the application of Gram-staining, direct 
mass spectrometry (MS), and molecular methods (9, 10).
FAPlus/FNPlus bottles, which contain adsorbent polymeric 
beads and thus prevent difficulty in interpreting Gram-staining 
results, became available in December 2011. Several clinical 
studies have already demonstrated the advantages of FAPlus/
FNPlus bottles over the earlier blood culture bottles (SA/SN 
or FA/FN bottles) (4, 11, 12). However, to the best of our knowl-
edge, no study has reported the comparison of the performance 
of FAPlus/FNPlus and the combination of SA/SN and FA/FN 
bottles.
Until September 2013, physicians at our hospital needed to 
ascertain whether a patient had received antimicrobial therapy 
before blood culture was performed because SA/SN and FA/FN 
bottles were used for patients without and with antimicrobial 
therapy, respectively. FAPlus/FNPlus bottles became available 
in Japan in April 2013, and in September 2013, our hospital 
switched from the combined use of SA/SN and FA/FN bottles 
to using FAPlus/FNPlus bottles for blood culture irrespective 
of whether the patient has received antibiotics. In the present 
study, the microorganism detection rate and the time to pos-
itivity (TTP), which are the recommended quality indicators 
for automated blood culture systems including blood culture 
bottles (12, 13), were investigated to compare the performance of 




Blood samples were collected in SA/SN or FA/FN bottles 
(BioMérieux Co., Ltd.) from September 2012 to August 2013 
and in FAPlus/FNPlus bottles (BioMérieux Co., Ltd.) from Sep-
tember 2013 to August 2014. Blood cultures were obtained from 
adult patients at the Japanese Red Cross Nagoya First Hospital 
(Nagoya, Japan), which is one of the major referral hospitals in 
Nagoya City with over 800 beds and 31 clinical departments.
Blood samples from patients with suspected bloodstream 
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infections were cultured as directed by the physicians as part of 
routine patient care. Throughout the study, we collected data on 
the types of blood culture bottles, bacterial identification results, 
and TTPs using the Laboratory Information System.
Blood culture bottles were incubated at 37°C under aerobic 
and anaerobic conditions in an automated BacT/Alert 3D system 
until a positive result was obtained or for up to 6 days. Micro-
organisms from positive blood cultures were further identified 
by using the Vitek MS system (BioMérieux Co., Ltd.) according 
to our routine procedures (14) and were further classified as 
pathogens or contaminants. When a blood culture yielded mi-
croorganisms commonly considered to be contaminants (e.g., 
coagulase-negative staphylococci, Corynebacterium species, Ba-
cillus species, or Cutibacterium acnes), the culture was considered 
to be contaminated as in previous studies (15-17). The TTP was 
defined as the interval from loading bottles into the automated 
blood culture system until the growth signal was obtained, and 
it was automatically recorded by the blood culture system. If 
multiple species of microorganisms were detected in one bottle, 
which was defined as a polymicrobial culture, the first positive 
result was used to determine the TTP. Both clinical and labora-
tory blood culture procedures were unchanged during the study 
period, except the introduction of FAPlus/FNPlus bottles.
The ethics committee of our hospital waived the need for eth-
ical approval and informed consent because of the retrospective 
and anonymized nature of the study.
Statistical analysis
Differences of nominal data were evaluated using the χ2-test. 
If a patient had multiple sets of positive blood cultures, the 
shortest TTP was used. The normality of the distribution of 
numerical data was examined by the Kolmogorov-Smirnov test, 
and the Mann-Whitney U test was performed if normality was 
not confirmed. All the tests were two-tailed, and P < 0.05 was 
considered to be statistically significant. Statistical analyses 
were performed with StatView 4.5 software (Abacus Concepts, 
Berkeley, CA) or modified R software (The R Foundation for 
Statistical Computing, Perugia, Italy).
RESULTS
The microorganism detection rate
During the first and second consecutive 12-month periods, 
8771 and 8035 blood culture sets were obtained from 3362 and 
2802 patients, respectively. Among them, the overall positive 
rates were 9.6% and 11.2%, respectively (Figure 1A). The micro-
organism detection rate was significantly higher when FAPlus/
FNPlus bottles were used than when a combination of SA/SN 
and FA/FN bottles was used (P < 0.001). When pathogens and 
contaminants were assessed separately (Figure 1B), the detec-
tion rate of pathogens was significantly higher when FAPlus/
FNPlus bottles were used (9.6%) than when SA/SN and FA/
FN bottles were used (7.9%, P < 0.001). However, no significant 
difference was found in the detection rate of contaminants be-
tween the two sets of bottles (1.7% vs. 1.6%, P = 0.515). Further 
analysis revealed that a significantly higher detection rate of 
Gram-positive cocci including Enterococcus and Streptococcus spe-
cies, nonfermentative Gram-negative bacilli (e.g., Pseudomonas 
aeruginosa and Stenotrophomonas maltophilia), Helicobacter cinaedi, 
and polymicrobial cultures was observed with FAPlus/FNPlus 
bottles than with the combination of SA/SN and FA/FN bottles 
(Table 1). Interestingly, H. cinaedi, which was included with other 
Gram-negative bacilli, was not detected when SA/SN and FA/
FN bottles were used, but it was found in nine culture sets when 
FAPlus/FNPlus bottles were used (P < 0.001).
Time to positivity
The TTP data for the two sets of bottles are compared in Table 
2 ; overall TTP was not significantly different in both the sets 
(median, 15 vs. 16 h ; P = 0.145), whereas the TTP for pathogens 
was significantly longer with FAPlus/FNPlus bottles than with 
SA/SN and FA/FN bottles (median, 14.9 vs. 13.3 h ; P = 0.014). 
Further analysis revealed that the TTP for Gram-negative ba-
cilli including Escherichia coli, Aeromonas species, Aggregatibacter 
segnis, Capnocytophaga ochracea, Capnocytophaga sputigena, Eikenel-
la corrodens, Haemophilus influenzae, Brevibacillus laterosporus, and 
non-identifiable Gram-negative bacilli were significantly longer 
Figure 1.　A, Overall detection rate of microorganisms in blood cultures. B, Detection 
rates of pathogens and contaminants.
92 T. Hattori, et al.  FAPlus/FNPlus blood culture bottles
when FAPlus/FNPlus bottles were used. The median TTP for H. 
cinaedi was 90 h [95% confidence interval (CI) ; range, 79.6-136.7 
h]. After excluding H. cinaedi, TTP for pathogens was also longer 
when FAPlus/FNPlus bottles were used (median, 14.8 h ; 95% 
CI ; range, 14.2-15.8 h vs. median, 13.3 h ; 95% CI ; range, 12.8-
14.2 h ; P = 0.036).
 
DISCUSSION
This study showed that the microorganism detection rate was 
higher and the TTP for pathogens was significantly longer when 
FAPlus/FNPlus bottles were used than when SA/SN and FA/
FN bottles were used.
Some researchers have already reported the superiority of 
FAPlus/FNPlus bottles over either SA/SN bottles or FA/FN 
bottles (4, 11, 12) ; however, the comparison of the performance 
of FAPlus/FNPlus bottles and combination of SA/SN and FA/
FN bottles is not yet reported. Interestingly, our study showed 
that FAPlus/FNPlus bottles might be superior for detecting 
Gram-positive cocci including Enterococcus and Streptococcus spe-
cies, nonfermentative Gram-negative bacilli, and H. cinaedi. Fu-
thermore, polymicrobial cultures were significantly more often 
found in FAPlus/FNPlus bottles. Because the mortality rate was 
reported to be 2.15 times higher in patients with polymicrobial 
bloodstream infections than in those with monomicrobial infec-
tions (18), the increased detection rate for polymicrobial cultures 
could have a profound clinical impact.
It is also noteworthy that nine cases of H. cinaedi infection 
were detected by the FAPlus/FNPlus bottles. H. cinaedi causes 
enteric or bloodstream infections, and bacteremia seems to 
be more common in Japan (19). Reports of the detection of H. 
cinaedi using the BacT/Alert blood culture system have been very 
limited (20) ; however, to the best of our knowledge, the present 
study is the first to show that the detection rate of H. cinaedi was 
increased when FAPlus/FNPlus bottles were used. Better de-
tection of H. cinaedi is important and has a great clinical impact, 
particularly in immunocompromized patients. Lee et al. reported 
that FAPlus/FNPlus bottles detected more pathogens, although 
a lower mean volume of blood was inoculated into FAPlus/
FNPlus bottles than into SA/SN bottles (12). Considering all 
our results together, the threshold of FAPlus/FNPlus bottles for 
positive blood culture is potentially lower than that of SA/SN or 
FA/FN bottles.
An increase of microorganism detection may be caused at the 
expense of a higher contamination rate (21, 22). However, our 
results showed that there was no significant difference in the 
contamination rates between the two sets of bottles. The con-
tamination rate in our study (1.6%-1.7%) was below the optimal 
contamination rate (3%) described in CLSI guidelines (23). The 
reason for this is not clear, but a possible explanation is good 
compliance of phlebotomists with the blood culture procedure 
throughout the two study periods with different sets of bottles.
TTP for pathogens is important with regard to patient man-
agement. Several studies have demonstrated a significant de-
crease in TTP with FAPlus/FNPlus bottles compared with FA/
FN or SA/SN bottles (11, 12). However, our findings were differ-
ent ; a significantly longer TTP was observed with pathogens, 
particularly Gram-negative bacilli including E. coli, in FAPlus/
FNPlus bottles than in SA/SN and FA/FN bottles. Indeed, a pre-
vious study investigated a small number of samples (11), and the 
other study did not comply with the recommended blood inocula-
tion volume (12). Our results show that FAPlus/FNPlus bottles 
might be inferior to SA/SN and FA/FN bottles in terms of TTP.
Table 1.　Microorganisms detected in blood cultures comparing  the two periods
Microorganism(s)
No. of isolates detected (%)




Pathogens 694 (7.9) 772 (9.6) < 0.001
Gram-positive cocci 228 (2.6) 272 (3.4) < 0.001
Staphylococcus aureus 89 (1.0) 90 (1.1) 0.506 
Enterococcus species 32 (0.4) 50 (0.6) 0.017 
Streptococcus species 97 (1.1) 124 (1.5) 0.013 
Other Gram-positive cocci 10 (0.1) 8 (0.1) 0.775 
Gram-negative bacilli 354 (4.0) 374 (4.7) 0.048 
Enterobacterales 311 (3.5) 280 (3.5) 0.830 
Nonfermentative Gram-negative bacilli 27 (0.3) 73 (0.9) < 0.001
Other Gram-negative bacilli 16 (0.2) 21 (0.3) 0.275 
Helicobacter cinaedi 0 (0.0) 9 (0.1) 0.001 
Gram-negative cocci 5 (0.1) 0 (0.0) 0.064 
Gram-positive bacilli 4 (0.0) 7 (0.1) 0.296 
Anaerobes 36 (0.4) 33 (0.4) 0.998 
Fungi 18 (0.2) 20 (0.2) 0.551 
Polymicrobial cultures 49 (0.6) 66 (0.8) 0.039 
Contaminants 151 (1.7) 128 (1.6) 0.515 
Coagulase-negative Staphylococci 106 (1.2) 85 (1.1) 0.357 
Bacillus species 25 (0.3) 24 (0.3) 0.870 
Corynebacterium species 6 (0.1) 12 (0.1) 0.109 
Cutibacterium acnes 14 (0.2) 7 (0.1) 0.184 
All microorganisms 845 (9.6) 900 (11.2) < 0.001
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This study had some limitations. The first was its before-vs.-af-
ter design, which introduces some confounders and is less power-
ful than a direct, synchronous comparison. It was also impossible 
to exclude selection bias such as changes in hospital care, patient 
characteristics, and infectious diseases. However, the two study 
periods were consecutive, and there were no changes in the blood 
culture procedures of our hospital. Indeed, the contamination 
rate was extremely low during both the periods. Second, we did 
not investigate whether patients received antimicrobial therapy 
before blood collection, so we could not assess the microorganism 
detection capacity of the FAPlus/FNPlus bottles for patients 
taking antimicrobial therapy. Kirn et al. reported an improved 
performance of FAPlus/FNPlus bottles compared with FA/FN 
bottles regardless of antimicrobial treatment (11). The superior 
performance of FAPlus/FNPlus bottles may be related to the 
inactivation of antibiotics as well as the inactivation of toxic 
compounds and cytokines. Finally, we did not record the blood 
volumes of each bottle. Blood volume is known to be the most 
important factor affecting the quality of a blood culture (24). 
Accordingly, a further study including blood volume information 
is warranted.
In conclusion, the pathogen detection rate was higher with 
FAPlus/FNPlus bottles than with the combination of SA/SN and 
FA/FN bottles. In particular, there was a significant increase in 
the detection of Enterococcus and Streptococcus species, nonfer-
mentative Gram-negative bacilli, H. cinaedi, and polymicrobial 
cultures. However, FAPlus/FNPlus bottles might be inferior to 
SA/SN and FA/FN bottles in terms of TTP. Our study suggests 
a lower threshold for positive blood cultures and lower bacterial 
growth rates in FAPlus/FNPlus bottles than in SA/SN and FA/
FN bottles.
Table 2.　 Time to positivity in blood cultures comparing the two periods
Microorganism(s)
Time to positivity (hours)
P valueSep 2012-Aug 2013(SA/SN and FA/FN)
Sep 2013-Aug 2014
(FAPlus/FNPlus)
No. Median 95% CI No. Median 95% CI
Pathogens 493 13.3 12.8-14.2 541 14.9 14.3-15.9 0.014 
Gram-positive cocci 163 14.1 13.2-15.5 185 14.8 13.7-15.8 0.407 
Staphylococcus aureus 59 14.6 13.2-18.4 60 17.5 14.8-18.3 0.288 
Enterococcus species 27 15.5 12.6-16.7 40 15.7 14.3-18.8 0.247 
Streptococcus species 68 12.9 11.1-14.0 80 12.1 11.2-13.8 0.668 
Other Gram-positive cocci 9 24.7 20.1-27.7 5 38.8 17.4-76.5 0.364 
Gram-negative bacilli 239 11.8 11.1-12.4 252 14.0 12.9-14.6 < 0.001
Enterobacterales 205 11.1 10.8-11.9 185 12.3 11.9-13.0 0.032 
Escherichia coli 98 10.9 10.1-11.8 112 12.0 11.3-13.0 0.043 
Klebsiella pneumoniae 59 10.8 9.6-13.7 29 12.2 10.5-15.8 0.303 
Klebsiella oxytoca 11 12.8 9.7-24.9 5 10.2 NA 0.743 
Proteus mirabilis 7 17.4 8.2-59.2 6 13.1 6.2-14.3 0.352 
Enterobacter cloacae complex 10 11.9 6.3-13.0 5 11.3 NA 0.667 
Other Enterobacterales a 20 14.2 13.0-28.9 28 15.2 14.0-23.7 0.917 
Nonfermentative Gram-negative bacilli 22 21.6 18.4-29.1 51 21.1 19.6-22.3 0.568 
Other Gram-negative bacilli 12 21.1 10.0-52.5 16 79.6 46.1-90.0 0.013 
Helicobacter cinaedi 0 7 90.0 79.6-136.7
Other Gram-negative bacilli excluding H. cinaedi b 12 21.1 10.0-51.1 9 39.8 21.5-69.4 0.345 
Gram-negative cocci 4 22.1 15.0-62.2 0
Gram-positive bacilli 3 22.9 17.4-25.2 5 39.4 20.9-60.4 0.393 
Anaerobes 27 51.5 28.8-64.8 28 36.6 31.1-41.3 0.386 
Fungi 17 38.3 33.4-52.1 16 36.1 24.3-59.1 0.829 
Polymicrobial cultures 40 15.2 12.1-20.6 55 14.1 12.8-17.8 0.684 
Contaminants 131 22.8 20.2-24.2 101 22.5 19.6-25.1 0.972 
Coagulase-negative Staphylococci 94 23.1 21.7-24.7 69 21.8 19.4-24.4 0.241 
Bacillus species 23 12.2 11.6-13.2 16 12.0 10.8-18.7 0.710 
Corynebacterium species 6 43.9 29.1-69.8 10 36.0 32.0-45.6 0.492 
Cutibacterium acnes 8 116.3 111.3-133.8 6 130.7 114.1-137.0 0.491 
All microorganisms 624 15.0 14.1-15.8 642 16.0 14.9-17.3 0.145 
NA, not applicable because of insufficient number of samples
a Other Enterobacterales includes Klebsiella aerogenes, Citrobacter koseri, Citobacter freundii, Citrobacter amalonaticus, Serratia marcescens, Cronobacter 
sakazakii, Cronobacter malonaticus, Morganella morganii, Pantoea dispersa, Salmonella group, Proteus vulgaris, Raoultella planticola, Raoultella ornithi-
nolytica, Edwardsiella hoshinae, Edwardsiella tarda, Hafnia alvei, and Leclercia adenocarboxylata.      
b Other Gram-negative bacilli excluding H. cinaedi includes Aeromonas species, Aggregatibacter segnis, Capnocytophaga ochracea, Capnocytophaga 
sputigena, Eikenella corrodens, Haemophilus influenzae, Brevibacillus laterosporus, and non-identifiable Gram-negative bacilli.
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